|
Market Closed -
Hong Kong S.E.
09:08:16 16/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 8.880 HKD | +0.17% |
|
-2.26% | +5.34% |
| 10-15 | CSPC Pharma Gets China Nod for Tumor Drug Trial | MT |
| 10-15 | CSPC Pharmaceutical Group Limited Obtains Clinical Trial Approval For SYS6088 Injection In China | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CSPC PHARMACEUTICAL GROUP LIMITED | Other Pharmaceuticals | +0.17% | -2.26% | +5.34% | +1.37% | +2.66% | 12.92B |  |  | |
- Stock Market
- Stocks
- 1093 Stock
- Charts CSPC Pharmaceutical Group Limited
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
